search
Back to results

Conversion to SADI-S, RYGB or OAGB After Failed Sleeve (RCTresleeve)

Primary Purpose

Weight Loss, Bariatric Surgery Candidate, Comorbidities and Coexisting Conditions

Status
Not yet recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
revision surgery
Sponsored by
General Committee of Teaching Hospitals and Institutes, Egypt
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Weight Loss focused on measuring RYGB, OAGB, SADI-S, Sleeve gastrectomy

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Undergone primary laparoscopic sleeve gastrectomy in the past Weight regain defined as any increase in weight above the nadir as reported by the patient BMI at the time of revisional surgery was around 45 kg/m2 weight regain was defined as an increase in BMI after bariatric surgery to exceed 35 With or without Gastroesophageal reflux disease (GERD) grade A and B o Patients with grade C or higher GERD, according to the Los Angeles (LA) classification [7] will be excluded from the study Exclusion Criteria: Didn't follow preoperative consultation Cannot give of sign informed consent

Sites / Locations

  • Madina Women's Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

RYGB procedure arm 1

OAGB procedure arm 2

SADI-S procedure arm 3

Arm Description

After failed sleeve, the patients will get a revisional procedure. The RYGB

After failed sleeve, the patients will get a revisional procedure. The OAGB

After failed sleeve, the patients will get a revisional procedure. The SADI-S

Outcomes

Primary Outcome Measures

The number of participants who will have early complications related to surgery
the incidence of re-operation, bleeding or leakages
The percentage Excess body weight loss (%EWL)
the amount of weight loss after revision surgery
somscore of food tolerance
validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance

Secondary Outcome Measures

Nutritional levels of albuminemia
the albuminemia level will be tested after surgery (g/dl)
Nutritional levels of proteinemia
the proteinemia level will be tested after surgery (mg/dl)
Nutritional levels of anemia
the anemia level will be tested after surgery (Mcl)
Nutritional levels of calcemic
the calcemic level will be tested after surgery (mg/dl)
Incidence of Reflux
GERD assessment
The number of participants who will have late complications related to surgery
the incidence of re-operations will be collected
Short Form 36 Quality of life
Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is).
VAS/NRS (incidence of pain)
pain scoring from 0-10 (0 is no pain 10 is most worst pain)
Metabolic biomarkers Glucagon-like peptide-1 (GLP1)
the GLP1 level will be tested after surgery (mg/ml)
Metabolic biomarkers Leptin
the Leptin level will be tested after surgery (mg/ml)
Metabolic biomarkers Peptide YY ( PYY)
the PYY level will be tested after surgery (pg/ml)
Metabolic biomarkers Ghrelin
the Ghrelin level will be tested after surgery (mg/ml)
Metabolic biomarkers Insulin
the Insulin level will be tested after surgery (million units/ml)

Full Information

First Posted
October 25, 2022
Last Updated
November 2, 2022
Sponsor
General Committee of Teaching Hospitals and Institutes, Egypt
search

1. Study Identification

Unique Protocol Identification Number
NCT05608772
Brief Title
Conversion to SADI-S, RYGB or OAGB After Failed Sleeve
Acronym
RCTresleeve
Official Title
Conversion of Failed Sleeve Gastrectomy Due to Weight Regain to SADI-S, RYGB or OAGB
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 1, 2023 (Anticipated)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
January 1, 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
General Committee of Teaching Hospitals and Institutes, Egypt

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Assess what revisional surgery is superior and provides the best weight loss after primary LSG. What is the occurrence of complications and the nutritional laboratory status? And if the resolution and /or improvement of associated medical problems after the weight loss will occur.
Detailed Description
Laparoscopic sleeve gastrectomy (LSG) gained popularity and has become one of the most performed weight loss procedures worldwide. In the long-term follow-up, the literature states that the incidence of gastroesophageal reflux disease (GERD) accounts for 16%, and weight regains accounting for 70% after LSG. These are the two most common complications which can necessitate further surgical intervention. The hypotheses are that laparoscopic conversion from LSG to Single anastomosis duodeno-ileal bypass (SADI-S), Roux-en-Y gastric bypass (RYGB), or one anastomosis gastric bypass (OAGB) will provide a new significant weight loss, improvement in obesity-related health problems and provide no nutritional deficiency in all cases. Since the three types of procedures have other anatomical presentations, whereby these is not well tested next to each other in a blinded, controlled setting for the patient, this study is designed to discover if the procedures are superior to each other or not and what the best outcome is for the patient. A sample size is calculated and with a medium effect size of 0.5 corresponds to a mean difference in %EBMIL between SADI-S, RYGB, and OAGB of at least 10%. Using a power of 0.8 with an alpha of 0.05 resulted in a sample size of 64 patients per group. Considering a possible loss of patients to follow-up, an additional 20% increase in sample size was included per group, resulting in a minimum of 78 patients per group. (Total of 3 groups together of 234 patients).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, Bariatric Surgery Candidate, Comorbidities and Coexisting Conditions, Nutrient Deficiency
Keywords
RYGB, OAGB, SADI-S, Sleeve gastrectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A single-blind randomization procedure, in which patients and outpatient clinic nurses will be blinded to the study period p
Masking
Participant
Allocation
Randomized
Enrollment
234 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
RYGB procedure arm 1
Arm Type
Active Comparator
Arm Description
After failed sleeve, the patients will get a revisional procedure. The RYGB
Arm Title
OAGB procedure arm 2
Arm Type
Active Comparator
Arm Description
After failed sleeve, the patients will get a revisional procedure. The OAGB
Arm Title
SADI-S procedure arm 3
Arm Type
Active Comparator
Arm Description
After failed sleeve, the patients will get a revisional procedure. The SADI-S
Intervention Type
Procedure
Intervention Name(s)
revision surgery
Intervention Description
revision procedure after failed sleeve gastrectomy
Primary Outcome Measure Information:
Title
The number of participants who will have early complications related to surgery
Description
the incidence of re-operation, bleeding or leakages
Time Frame
6 weeks
Title
The percentage Excess body weight loss (%EWL)
Description
the amount of weight loss after revision surgery
Time Frame
3,6,12,24 months
Title
somscore of food tolerance
Description
validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance
Time Frame
2,6 weeks and 3,6,12,24 months
Secondary Outcome Measure Information:
Title
Nutritional levels of albuminemia
Description
the albuminemia level will be tested after surgery (g/dl)
Time Frame
3,6,12,24 months
Title
Nutritional levels of proteinemia
Description
the proteinemia level will be tested after surgery (mg/dl)
Time Frame
3,6,12,24 months
Title
Nutritional levels of anemia
Description
the anemia level will be tested after surgery (Mcl)
Time Frame
3,6,12,24 months
Title
Nutritional levels of calcemic
Description
the calcemic level will be tested after surgery (mg/dl)
Time Frame
3,6,12,24 months
Title
Incidence of Reflux
Description
GERD assessment
Time Frame
3,6,12,24 months
Title
The number of participants who will have late complications related to surgery
Description
the incidence of re-operations will be collected
Time Frame
3,6,12,24 months
Title
Short Form 36 Quality of life
Description
Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is).
Time Frame
3,6,12,24 months
Title
VAS/NRS (incidence of pain)
Description
pain scoring from 0-10 (0 is no pain 10 is most worst pain)
Time Frame
3,6,12,24 months
Title
Metabolic biomarkers Glucagon-like peptide-1 (GLP1)
Description
the GLP1 level will be tested after surgery (mg/ml)
Time Frame
3,6,12,24 months
Title
Metabolic biomarkers Leptin
Description
the Leptin level will be tested after surgery (mg/ml)
Time Frame
3,6,12,24 months
Title
Metabolic biomarkers Peptide YY ( PYY)
Description
the PYY level will be tested after surgery (pg/ml)
Time Frame
3,6,12,24 months
Title
Metabolic biomarkers Ghrelin
Description
the Ghrelin level will be tested after surgery (mg/ml)
Time Frame
3,6,12,24 months
Title
Metabolic biomarkers Insulin
Description
the Insulin level will be tested after surgery (million units/ml)
Time Frame
3,6,12,24 months
Other Pre-specified Outcome Measures:
Title
The number of participants who will have late complications related to surgery
Description
the incidence of re-operations or complications will be collected
Time Frame
60 months
Title
The number of participants whereby revision surgery necessary after the RCT
Description
the incidence of re-operations or other procedure will be collected
Time Frame
60 months
Title
The percentage Excess body weight loss (%EWL)
Description
the amount of weight loss after revision surgery
Time Frame
60 months
Title
Incidence of Reflux
Description
GERD classification
Time Frame
60 months
Title
Nutritional levels of albuminemia
Description
the albuminemia level will be tested after surgery (g/dl)
Time Frame
60 months
Title
Nutritional levels of proteinemia
Description
the proteinemia level will be tested after surgery (mg/dl)
Time Frame
60 months
Title
Nutritional levels of anemia
Description
the anemia level will be tested after surgery (Mcl)
Time Frame
60 months
Title
Nutritional levels of calcemic
Description
the calcemic level will be tested after surgery (mg/dl)
Time Frame
60 months
Title
Somscore of food tolerance
Description
validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance
Time Frame
60 months
Title
Short Form 36 Quality of life
Description
Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is).
Time Frame
60 months
Title
VAS/NRS (incidence of pain)
Description
pain scoring from 0-10 (0 is no pain 10 is most worst pain)
Time Frame
60 months
Title
Metabolic biomarkers Glucagon-like peptide-1 (GLP1)
Description
the GLP1 level will be tested after surgery (mg/ml)
Time Frame
60 months
Title
Metabolic biomarkers Leptin
Description
the Leptin level will be tested after surgery (mg/ml)
Time Frame
60 months
Title
Metabolic biomarkers Peptide YY ( PYY)
Description
the PYY level will be tested after surgery (pg/ml)
Time Frame
60 months
Title
Metabolic biomarkers Ghrelin
Description
the Ghrelin level will be tested after surgery (mg/ml)
Time Frame
60 months
Title
Metabolic biomarkers Insulin
Description
the Insulin level will be tested after surgery (million units/ml)
Time Frame
60 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Undergone primary laparoscopic sleeve gastrectomy in the past Weight regain defined as any increase in weight above the nadir as reported by the patient BMI at the time of revisional surgery was around 45 kg/m2 weight regain was defined as an increase in BMI after bariatric surgery to exceed 35 With or without Gastroesophageal reflux disease (GERD) grade A and B o Patients with grade C or higher GERD, according to the Los Angeles (LA) classification [7] will be excluded from the study Exclusion Criteria: Didn't follow preoperative consultation Cannot give of sign informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bart Torensma, PHD
Phone
+31641389070
Email
bart@torensmaresearch.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Mohamed Ashour, MD
Phone
+201002600970
Email
mohamed.ashour@alexu.edu.eg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohamed Ashour, MD
Organizational Affiliation
University of Alexandria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Madina Women's Hospital
City
Alexandria
ZIP/Postal Code
21531
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
FAIR data of this study can be requested. All will be saved in the Castor Electronic data capture system.
IPD Sharing Time Frame
After 2 and 5 years and after full analysis and publication the data will be available and stored for minimal 10 years.
IPD Sharing Access Criteria
Email the Principal investigator. Whereby access to an annonymous database site will be created.
Citations:
PubMed Identifier
30903425
Citation
Guan B, Chong TH, Peng J, Chen Y, Wang C, Yang J. Mid-long-term Revisional Surgery After Sleeve Gastrectomy: a Systematic Review and Meta-analysis. Obes Surg. 2019 Jun;29(6):1965-1975. doi: 10.1007/s11695-019-03842-3.
Results Reference
result
PubMed Identifier
32636173
Citation
Lazzati A, Bechet S, Jouma S, Paolino L, Jung C. Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis. 2020 Oct;16(10):1497-1504. doi: 10.1016/j.soard.2020.05.021. Epub 2020 May 29.
Results Reference
result
PubMed Identifier
29625744
Citation
Clapp B, Wynn M, Martyn C, Foster C, O'Dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018 Jun;14(6):741-747. doi: 10.1016/j.soard.2018.02.027. Epub 2018 Mar 6.
Results Reference
result
PubMed Identifier
32738545
Citation
Parmar CD, Gan J, Stier C, Dong Z, Chiappetta S, El-Kadre L, Bashah MM, Wang C, Sakran N. One Anastomosis/Mini Gastric Bypass (OAGB-MGB) as revisional bariatric surgery after failed primary adjustable gastric band (LAGB) and sleeve gastrectomy (SG): A systematic review of 1075 patients. Int J Surg. 2020 Sep;81:32-38. doi: 10.1016/j.ijsu.2020.07.007. Epub 2020 Jul 29.
Results Reference
result
PubMed Identifier
30542828
Citation
Chiappetta S, Stier C, Scheffel O, Squillante S, Weiner RA. Mini/One Anastomosis Gastric Bypass Versus Roux-en-Y Gastric Bypass as a Second Step Procedure After Sleeve Gastrectomy-a Retrospective Cohort Study. Obes Surg. 2019 Mar;29(3):819-827. doi: 10.1007/s11695-018-03629-y.
Results Reference
result
PubMed Identifier
33432483
Citation
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obes Surg. 2021 May;31(5):1937-1948. doi: 10.1007/s11695-020-05207-7. Epub 2021 Jan 12.
Results Reference
result
Citation
Sami S, Ragunath K. The Los Angeles Classification of Gastroesophageal Reflux Disease. Video Journal and Encyclopedia of GI Endoscopy. 2013;1:103-4.
Results Reference
result

Learn more about this trial

Conversion to SADI-S, RYGB or OAGB After Failed Sleeve

We'll reach out to this number within 24 hrs